The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,973.00
Bid: 1,971.00
Ask: 1,972.00
Change: 17.00 (0.87%)
Spread: 1.00 (0.051%)
Open: 1,963.00
High: 1,994.00
Low: 1,959.00
Prev. Close: 1,956.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Ex-div stocks weigh on FTSE 100 early on

Wed, 13th Mar 2013 08:33

Traders chose to take profits on Wednesday morning, taking advantage of the strong gains seen in previous sessions, with the FTSE 100 pulling back sharply from five-year highs.So far this year, the index has gained nearly 10% and is trading near levels not seen since late 2007.According to Reuters, ex-dividend stocks were accounting for 10.71 points of the fall on the Footsie this morning with traders unable to get their hands on the most recent payouts from big-hitters like British American Tobacco, Hargreaves Lansdown, Land Securities, Meggitt, Serco and Standard Chartered.A poor reaction to the latest results of security solutions giant G4S was also weighing on London's benchmark index early on.Traders will be looking out for a number of key economic announcements due later on, including Eurozone industrial production, a medium- to long-term bond auction in Italy, and advance retail sales and business inventories in the States.In other news, Christian Menegatti, the head of research at Roubini Global Economics, has said that the Federal Reserve won't stop its quantitative easing programme before the end of 2014 as it will take time to get down to the 7.25% jobless rate signalled by the central bank.G4S drops as CFO steps downG4S was among the worst performers on the FTSE 100 early on after announcing the resignation of Chief Financial Officer (CFO) Trevor Dighton. The news came as the firm unveiled a 10.4% rise in 2012 revenues despite taking a hit over its London Olympic contract blunder.Insurance giant Prudential rose strongly after reporting a 25% increase in operating profit in 2012. The company said its performance was largely driven by its "sweet-spot" markets including Indonesia, Singapore, Malaysia, the Philippines and Thailand.Iron ore specialist Ferrexpo rose strongly after revealing a special dividend of 6.6 cents per share (totalling $39m) in its 2012 results despite a 20% fall in revenue.Hikma Pharmaceuticals fell early on after saying that revenue growth would slow to 10% in 2013 from 20.8% last year.Oil and gas group Afren edged higher after reporting positive test results from the Simrit-2 well on the Ain Sifni Block in the Kurdistan region of Iraq.Meanwhile, newly-listed insurance group Direct Line was under the weather on reports that RBS is looking to further reduce its stake in the company.Copper miner Antofagasta gained after HB Markets upgraded its rating on the stock to 'buy', while infrastructure firm Balfour Beatty was lower after HSBC downgraded the shares to 'neutral'.FTSE 100 - RisersPrudential (PRU) 1,049.00p +1.94%Imperial Tobacco Group (IMT) 2,399.00p +0.80%Severn Trent (SVT) 1,645.00p +0.61%National Grid (NG.) 744.00p +0.40%Sage Group (SGE) 343.50p +0.32%Sainsbury (J) (SBRY) 350.30p +0.32%Intu Properties (INTU) 328.50p +0.31%Hammerson (HMSO) 507.00p +0.30%Admiral Group (ADM) 1,348.00p +0.30%United Utilities Group (UU.) 716.00p +0.28%FTSE 100 - FallersStandard Chartered (STAN) 1,730.50p -3.24%G4S (GFS) 299.60p -2.57%British American Tobacco (BATS) 3,520.50p -2.56%Capita (CPI) 872.50p -2.35%Aggreko (AGK) 1,845.00p -2.17%Evraz (EVR) 255.30p -2.07%Kazakhmys (KAZ) 541.00p -1.99%Meggitt (MGGT) 481.30p -1.72%Serco Group (SRP) 615.00p -1.68%Schroders (SDR) 2,130.00p -1.39%FTSE 250 - RisersMan Group (EMG) 101.30p +3.16%Ferrexpo (FXPO) 225.90p +2.68%SDL (SDL) 455.50p +2.59%Synthomer (SYNT) 217.90p +1.40%Raven Russia Ltd (RUS) 72.80p +1.39%Law Debenture Corp. (LWDB) 486.00p +1.33%Redrow (RDW) 173.10p +1.23%Bumi (BUMI) 342.70p +1.18%JD Sports Fashion (JD.) 814.50p +1.05%Regus (RGU) 156.60p +1.03%FTSE 250 - FallersBalfour Beatty (BBY) 257.70p -5.26%Premier Farnell (PFL) 229.10p -3.05%Direct Line Insurance Group (DLG) 205.20p -2.38%Petropavlovsk (POG) 243.60p -2.33%Fidelity European Values (FEV) 1,431.00p -1.99%Domino's Pizza Group (DOM) 575.00p -1.96%Temple Bar Inv Trust (TMPL) 1,112.00p -1.94%William Hill (WMH) 413.20p -1.76%Kier Group (KIE) 1,242.00p -1.74%Informa (INF) 516.50p -1.71%BC
More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.